News &

Press

venBio news

“venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies.”

“venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences.”

“venBio Closes $394 Million Life Sciences Venture Capital Fund.”

Portfolio news

Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering

Aug 18, 2020

Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering

Aug 6, 2020

ALX Oncology Announces Pricing of Initial Public Offering

Jul 16, 2020

Akero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients

Jun 30, 2020

Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer

Jun 26, 2020

Checkmate Pharmaceuticals Secures $85 Million in Series C Financing

Jun 10, 2020

Roche makes a platform play, betting $190M in cash on Arrakis’ long-haul plans to drug RNA

Apr 8, 2020

San Francisco office

1700 Owens Street, Suite 595
San Francisco, CA 94158

Seattle office

1200 Westlake Ave N, Suite 900
Seattle, WA 98109

© 2024 venBio. All Rights Reserved.